SARS-CoV-2 progressed from animal-to-human to human-to-human transmission, causing mild to severe sickness and numerous deaths, verifying two criteria for calling COVID-19 a pandemic. The disease's symptoms progress from mild to severe pneumonia to respiratory and multi-visceral failure, which generally kills comorbid individuals quickly. Intensive global research is undertaken to elucidate viral transmission channels and host defensive mechanisms. Due to its high infectious potential, researchers are repurposing antivirals and other potential inhibitors to build effective diagnostics and therapeutics.
President Heart Care Foundation of India and Group Editor in Chief MEDtalks
Recipient of Padma Shri, Vishwa Hindi Samman, National Science Communication Award and Dr B C Roy National Award, Dr Aggarwal is a physician, cardiologist, spiritual writer and motivational speaker. He was the Past President of the Indian Medical Association and President of Heart Care Foundation of India. He was also the Editor in Chief of the IJCP Group, Medtalks and eMediNexus
Senior Consultant, Department of Infectious Disease at Apollo Hospitals, Chennai
Dr. V Ramasubramanian is a Senior Consultant, Department of Infectious Disease at Apollo Hospitals, Chennai, Director Capstone Clinic, Chennai, Prof. Infectious Diseases, Sri Ramachandra Institute of Higher Education & Research, Member in the Advisory Panel to the Government for COVID-19 Management in the State.